J Gynecol Oncol.  2012 Apr;23(2):78-79. 10.3802/jgo.2012.23.2.78.

How to make the best strategy to manage thromboembolism in ovarian cancer?

• Lim MC
• Park SY

• KMID: 2177578
• DOI: http://doi.org/10.3802/jgo.2012.23.2.78

Abstract

No abstract available.

MeSH Terms

Thromboembolism

Reference

1. National Comprehensive Cancer Network. NCCN guideline: venous thromboembolic disease [Internet]. 2012. cited 2012 Mar 19. Fort Washington, PA: National Comprehensive Cancer Network;Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

2. Lim MC, Park SH, Park SY. Ovarian clear cell carcinoma: high risk of venous thromboembolism. Gynecol Oncol. 2010. 118:317.

3. Lim MC, Lee HS, Kang S, Seo SS, Lee BY, Park SY. Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma. Arch Gynecol Obstet. 2010. 281:329–334.

4. Kawaguchi R, Furukawa N, Kobayashi H. Cut-off value of D-dimer for prediction of deep venous thrombosis before treatment in ovarian cancer. J Gynecol Oncol. 2012. 23:98–102.